The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
711 - Can patient survey data from CADTH be used for an unbranded tool on current patient experience and behaviour?
-
CADTH is an important tool for explaining recommendations for funding decisions, but it is not designed or intended to support product claims in drug advertising. See AskPAAB question 541 for more information on this topic. For claims related to patient experience and behaviour which do not relate to pharmacotherapy (i.e. disease attitude and opinions), then we may consider surveys as a source depending on the design, and execution of the survey. However, the primary source to support these claims should be the survey itself, not the CADTH document.
